Efficacy and safety assessment of Centella asiatica as an herbal dietary supplement to reduce blood sugar levels in type II diabetes patients in Thailand.
Phase 1
- Conditions
- Type II diabetes
- Registration Number
- TCTR20230928003
- Lead Sponsor
- The Royal College of Physicians of Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1. Type II Diabetes patient
2. Age 18-65 years old
Exclusion Criteria
1. Pregnancy or lactation
2. Type I diabetes
3. HbA1c level >= 10
4. On insulin treatment
5. Hypothyroidism or hyperthyroidism
6. Severe liver dysfunction within 6 months : alanin aminotransferase (ALT) or aspartate amionotransferase (AST) > 5 times of normal limit, INR > 6.5, Bilirubin > 17.5 mg/dL
7. Creatinine > 3.5 mg/dL or eGFR < 30 ml/min/1.73 m2 within 6 months
8. Severe allergy to Centella asiatica
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method